EMERALD ADVISERS, LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q2 2021$340,000
-44.0%
2,712
-39.4%
0.01%
-45.5%
Q1 2021$607,000
+2.0%
4,473
-3.9%
0.02%
+10.0%
Q4 2020$595,000
+94.4%
4,653
+71.2%
0.02%
+53.8%
Q3 2020$306,0002,7180.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 2$3580.00%
View complete list of ACCELERON PHARMA INC shareholders